drugset / Trial / NCT01871740

CSPPT- Chronic Kidney Diseases Study

NCT01871740 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing renal function decline among the patients with primary hypertension when compared to enalapril maleate.

Timeline

Start
2008-05
Primary completion
2014-06
Completion
2014-08

Outcome

Outcome not reported

Stopped: “The sponsor and the PIs both agreed that the CSPPT-CKD should be a sub-study of the CSPPT insted of an independent randomized trial.”

Drugs

EvaluationDrugModalityDoseRoute
Subject folic acid Other / unclassified 0.8 mg Oral
Comparator Enalapril Other / unclassified 10 mg Oral